FILING ANALYSIS · WEDNESDAY, AUGUST 12

Relief Therapeutics Holding Sa 0QKQ — RNS

neutral

The appointment of Prof. John W. Krakauer as a strategic advisor is a positive development for MindMaze Therapeutics, but it lacks quantified financial impact, so it's unlikely to significantly move the stock price of Relief Therapeutics Holding Sa. The announcement is more relevant to MindMaze Therapeutics, which is a different company.

The filing

Relief Therapeutics Holding Sa — Mindmaze Therapeutics Appoints Prof John W

Read the RNS announcement →

How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.

Get filings like this every market day

The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.

Subscribe free →